[Initial clinical and hematological findings on the use of sarcochlorine in the treatment of various malignant blood and lymph node lymphatic diseases].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D007938:Leukemia; D007951:Leukemia, Myeloid / Q000628:therapy*; D008198:Lymph Nodes; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D010649:Phenylalanine / Q000031:analogs & derivatives; D012509:Sarcoma
D000970:Antineoplastic Agents; D010649:Phenylalanine
CYTOTOXIC DRUGS/therapeutic use; HODGKIN'S DISEASE/therapy; LEUKEMIA, MYELOCYTIC/therapy; PHENYLALANINE/related compounds; SARCOMA, RETICULUM CELL/therapy
Prime osservazioni cliniche ed ematologiche sull'impiego della sarcoclorina nel trattamento di alcune emolinfopatie maligne.